Evidence map›Paper›PMID 39057941›Full record

ArticleToxins2024

Toxic Peptides from the Mexican Scorpion

Lidia Riaño-Umbarila, Timoteo Olamendi-Portugal, José Alberto Romero-Moreno, Gustavo Delgado-Prudencio, Fernando Z Zamudio, Baltazar Becerril, Lourival D Possani

Abstract read
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lidia Riaño-UmbarilaInvestigadora por México, CONAHCYT, Mexico City 03940, Mexico.ORCID 0000-0002-2531-9232
Timoteo Olamendi-PortugalDepartamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.
José Alberto Romero-MorenoDepartamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.
Gustavo Delgado-PrudencioDepartamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.ORCID 0000-0002-7977-9269
Fernando Z ZamudioDepartamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.
Baltazar BecerrilDepartamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.
Lourival D PossaniDepartamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.ORCID 0000-0001-6357-2661

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologia de Mexico 303045Direccion General de Asuntos del Personal Academicos of National Autonomous University of Mexico IN200323
6 · The paper itself

Abstract

Alternative recombinant sources of antivenoms have been successfully generated. The application of such strategies requires the characterization of the venoms for the development of specific neutralizing molecules against the toxic components. Five toxic peptides to mammals from the Mexican scorpion

Indexed as

PeptidesScorpionsScorpion VenomsSingle-Chain AntibodiesAmino Acid SequenceAnimalsAnimals, PoisonousAntiveninsHumansMiceAntiveninsPeptidesScorpion VenomsSingle-Chain AntibodiesC. villegasirecognitionscorpion toxinssingle-chain fragment variable (scFv)

Identifiers

PMID39057941
PMCPMC11280942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.